Chinese traditional medicine company’s shares surge on Covid outbreak
The stake held by the founding family of one of China’s largest traditional medicine groups has rocketed in value to $4.5bn after the latest Covid-19 outbreaks in the country triggered a renewed surge of interest in its coronavirus treatment.
Although the US has explicitly warned against the company’s medicine, shares in billionaire Wu Yiling’s pharmaceutical company Shijiazhuang Yiling Pharmaceutical have jumped more than 60 per cent since the end of December. The latest rally came on top of the stock’s 160 per cent gain in early 2020 after Beijing’s endorsement of its Covid treatment.
Shijiazhuang Yiling’s stock price had hovered at about Rmb8 ($1.26) before the pandemic, but it recently rose to record levels after the medicine was promoted in Hong Kong, closing out last week at Rmb31.5. The rally has boosted the value of the owning family’s almost 55 per cent stake in the company, listed on the Shenzhen Stock Exchange, to about Rmb28.8bn.
Wu is famous in China for developing a remedy out of centipede, scorpion, leech and cicada to treat cardiovascular diseases. His company sells a separate herbal remedy called Lianhua Qingwen, with ingredients including honeysuckle, liquorice root, apricot seed and forsythia, as a treatment for coronavirus. The remedy from Wu’s company was endorsed by both Zhong Nanshan, an expert advising the Chinese government on coronavirus, and Hong Kong’s leader Carrie Lam.
Hong Kong has been reeling from its biggest Covid outbreak of the pandemic while cases are also climbing in China, forcing the financial centre of Shanghai and other cities into lockdown.
Beijing has actively promoted traditional Chinese medicine on the global stage in recent years, and state media has trumpeted Shijiazhuang Yiling’s success in gaining regulatory approval in African and Middle Eastern countries.
But the US Food and Drug Administration, as well as Singaporean and Australian authorities, have warned that there was no evidence that Lianhua Qingwen had any effect on the virus, and cautioned against its use.
The FDA said claims that Lianhua Qingwen could prevent or treat Covid were “not supported by competent and reliable scientific evidence”, while Singaporean authorities said in November that there was “no scientific evidence” to show it can be used to prevent or treat Covid.
The company’s dramatic stock rise began after Lianhua Qingwen was recommended in Beijing’s official treatment protocols for coronavirus in March 2020.
Wu owns a 31.5 per cent stake in the company, while his son and daughter Wu Xiangjun and Wu Rui collectively hold 23 per cent, according to the company’s latest quarterly report.
From mid-2020 to late 2021 Shijiazhuang Yiling’s share price was volatile but slid downwards as China and Hong Kong appeared to have succeeded in containing the virus.
A version of the drug that was distributed in mainland China was initially not approved in Hong Kong, and local health authorities raided pharmacies that were selling it as recently as February.
But pro-Beijing lawmakers pressured the Hong Kong government in March, at the peak of the territory’s Omicron wave, to offer exemptions to batches of the medicine. Mainland companies have donated hundreds of thousands of packs to the city.
Pharmacists working in Hong Kong said they feared the spread of counterfeit versions of the remedy.
“The question is whether there will be counterfeit versions being sold in Hong Kong and if citizens can manage to recognise them,” said pharmacist Philip Chan. “Without undergoing proper registration, medicines could become a public health concern.”
Original article by admin, if reproduced, please cite the source as: https://www.tcmha.com/tcmnews/chinese-traditional-medicine-companys-shares-surge-on-covid-outbreak.html
相关推荐
-
Confusion and falsehoods spread as China reverses its ‘zero-COVID’ policy
After nearly three years of strict “zero-COVID” policies, in recent days Chinese officials have rolled back most of them following rare protests across the country. Mass testing and mass quarantining are now things of the past.
-
Chinese doctors train Cameroonian medical personnel in traditional medicine
The 21st batch of the China medical team in Cameroon on Wednesday organized a day-long lecture about Traditional Chinese medicine (TCM) for medical personnel at the Gynaeco-Obstetric and Paediatric Hospital in the capital, Yaounde. About 50 nurses and doctors turned up for the lecture given by two TCM experts. “It (acupuncture lecture) has never happened before in our country. So we want to begin with it and hope that we can go further. This bilateral collaboration with the government of China is very good and we are really getting the…
-
TCM effective in treating respiratory, lung diseases, experts say
Regarding interstitial lung diseases — illnesses that cause scarring of the lungs, Zhang said TCM medicines can help lower dosage of hormone, alleviate side effects of hormone and enhance immunity of patients.
-
China’s Ginseng Industry: Key ingredient in Traditional Chinese Medicine gets development boost
In the past couple of years, the city of Tonghua has been upgrading the ginseng industrial structure. Raw ginseng farming and trade – the centuries-old practices – were gradually replaced with ginseng processing and marketing. The city has developed many ginseng cosmetics and health supplements brands of its own.
-
JD.com : Health Opens Internet Hospital in Tianjin to Bring Traditional Chinese Medicine Services Online
In close collaboration with JD Health, the Internet hospital of the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (TCM) was launched on December 26th, marking a big step towards the “Internet + TCM” model, in which Tianjin residents can easily make online appointments with TCM doctors and order medications for home delivery. During the opening ceremony, Xuemin Shi, China’s TCM master and an academician of the Chinese Academy of Engineering, stated that Internet hospitals, big data, AI, and other innovative technologies will play an increasingly important role…
-
Covid-19: Mainland traditional Chinese medicine experts in Hong Kong offer treatment guidelines
A group of mainland Chinese experts have met with Hong Kong health officials to draft plans to use traditional Chinese medicine in Covid-19 clinical treatment as the city’s fifth-wave case fatality rate climbs. Secretary for Food and Health Sophia Chan met with the experts sent by the central authorities on Tuesday. The group, which arrived in the city last Tuesday, is part of Beijing’s efforts to aid the city’s anti-epidemic efforts, according to a government statement. Since their arrival, the delegation of seven traditional Chinese medicine experts has visited elderly…
-
Trendy ‘ear seeds’ may treat aches and illness — and look cute to boot
Although it sounds like a practice involving pouring seeds into one’s ear, it is described by health professionals as acupuncture for the ear — and patients are claiming the treatment changed their life.
-
China composes TCM therapy for patients with Omicron by studying their syndromes
China will study traditional Chinese medicine (TCM) therapy to treat patients with the Omicron strain, experts with the National Administration of Traditional Chinese Medicine said on Thursday. Practitioner said TCM could play a bigger role in COVID-19 treatment if patients with the Omicron strain showed mild symptoms or none, as studies showed, as TCM has proven effective in treating COVID-19 patients through reducing their symptoms and adjusting their immune systems. The application of TCM on Omicron-infected patients will be studied, and a treatment plan using TCM to target the Omicron…
-
Minister reveals plans to build center for traditional Chinese medicine in Belarus
The Center for Traditional Chinese Medicine (TCM) to be built in Belarus will follow the same philosophy as similar centers in China, Healthcare Minister Dmitry Pinevich told the Panorama program on the Belarus 1 TV channel, BelTA informs.
-
China turns to lemons, peaches and traditional medicine in wake of Covid wave
Covid cases in China saw a spike following the country’s relaxation of strict Covid rules. Also rising: the prices of traditional Chinese medicine and lemons, as Chinese citizens scramble for protection from the virus.Prices of fruits rich in vitamin C and antioxidants are seeing surges due to higher demand.Shares of Chinese pharmaceutical companies involved in the production of traditional Chinese medicine also notched their highest figures in a year in early December.
